Immune Pharmaceuticals Cổ tức 2024

Immune Pharmaceuticals làm gì?

Immune Pharmaceuticals Inc is a biopharmaceutical company specialized in the development and commercialization of novel therapies for the treatment of inflammatory diseases and cancer. The company, headquartered in Israel, was founded in 2010 and has branches in the USA and Europe. History: Immune Pharmaceuticals started as a subsidiary of EpiCept Corporation, a biopharmaceutical company focused on the development of pain medications. In October 2009, EpiCept and Immune Pharmaceuticals separated due to the growing interest in inflammatory body response and cancer therapy. Since the split, the company has made progress in the development of medications based on a proven active ingredient, AmiKet. Business model: Immune Pharmaceuticals aims for the successful development and commercialization of innovative products for the treatment of inflammatory diseases and cancer. The company focuses on the discovery and development of medications that influence the role of leukocytes and cytokines in the inflammatory response. The company relies on partnerships with other leading companies and government authorities in the development of therapies. Divisions: Immune Pharmaceuticals has two business divisions. The first division, Immuno-Dermatology, focuses on the development of medications for the treatment of inflammatory diseases such as psoriasis and eczema. The second division, Immuno-Oncology, aims to develop groundbreaking cancer therapies to improve the survival rate of cancer patients. Products: Unfortunately, most of the products developed by Immune Pharmaceuticals are still in the preclinical development phase and need to prove themselves in clinical trials to be approved by the FDA and brought to the market. One of the most well-known products is the medication Bertilimumab, which is in development for the treatment of inflammatory bowel diseases and progressive supranuclear palsy (PSP). Additionally, Immune is also working on the development of nanoparticle therapies that target cancer cells. Summary: Immune Pharmaceuticals is a biopharmaceutical company specialized in the development of therapies for the treatment of inflammatory diseases and cancer. The company has two business divisions, Immuno-Dermatology and Immuno-Oncology, and is currently developing a portfolio of medications to increase the survival rate of cancer patients and alleviate inflammatory diseases such as psoriasis and eczema. The company has undergone a promising phase of medication development, and it remains to be seen if it will be able to bring these medications to the market. Immune Pharmaceuticals là một trong những công ty được yêu thích nhất trên Eulerpool.com.